A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

Clinical trial NCT02415842 · COMPLETED

Trial details

NCT number: NCT02415842
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Immunologic Tests

Start date: 2015-10-26
Primary completion: 2018-02-16
Enrollment: 414

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.